{"id":151578,"name":"MT PHARMA AMERICA, INC.","slug":"mt-pharma-america-inc","state":"NJ","country":"United States of America","description":"Pharmaceutical Company","totalSpending":800000,"filings":27,"yearlySpending":[{"year":2018,"income":120000},{"year":2019,"income":120000},{"year":2020,"income":120000},{"year":2021,"income":120000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":80000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["WILLIAMS AND JENSEN, PLLC"],"lobbyists":["GEORGE OLSEN","KARINA LYNCH","CHERYL JAEGER","DAVID STARR","NICOLE BERTSCH"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act.","Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act.","Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act.","Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act.","Matters affecting access to and pricing of pharmaceuticals."]}